Stay updated on Tralokinumab Combo in Japanese AD: Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.

Latest updates to the Tralokinumab Combo in Japanese AD: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about the trial for atopic dermatitis, specifically regarding the masking procedures and the revision number has changed from v2.14.4 to v2.15.0. Key details about the trial's primary and secondary objectives, as well as inclusion and exclusion criteria, have been removed.SummaryDifference20%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 11, 2025.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check52 days agoChange DetectedThe webpage has updated its last update date to March 11, 2025, and removed previous update dates from August 14, 2024, and July 23, 2024. Additionally, significant information regarding IPD Sharing Access Criteria and related details has been deleted.SummaryDifference2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Tralokinumab Combo in Japanese AD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab Combo in Japanese AD: Clinical Trial page.